NIH PA-25-425: Parent F30 Fellowship for Dual-Degree Students at Institutions Without NIH-Funded Dual-Degree Programs

NIH PA-25-425: Parent F30 Fellowship for Dual-Degree Students at Institutions Without NIH-Funded Dual-Degree Programs

If your institution does not have an NIH-funded Medical Scientist Training Program (MSTP), Dental Scientist Training Program (DSTP), or similar NIH-funded predoctoral dual-degree track, PA-25-425 is the direct NIH pathway for that group. It is a recurring Ruth L. Kirschstein National Research Service Award (NRSA) Parent F30 opportunity that supports predoctoral clinician-researcher trainees in combined dual-degree programs, such as MD/PhD or DO/PhD, when they can show a strong research project, mentor support, and a training environment that can sustain both graduate and clinical components.

NIH does not position this opportunity as a one-time call; it runs with the standard NIH AIDS cycle and is explicitly listed with dates through 2028 in the current notice. That is why this page focuses on practical readiness for upcoming 2026/2027 cycles, not just the exact wording in 2025 notices.

Key details at a glance

What this opportunity actually funds

This is a program-eligible parent NOFO. You do not apply to one tightly defined thematic science topic (for example, a single disease area); you apply for your own integrated dual-degree training and research project. NIH uses the “parent” model to make one framework available to multiple Institutes and Centers (ICs) that have agreed to participate.

The NOFO explicitly states it supports predoctoral dual-degree students at schools without NIH-funded institutional predoctoral dual-degree training programs, with the goal of strengthening clinician-scientist pipeline development in health-related fields. In practical terms, an F30 candidate must propose a plan that combines rigorous graduate research and clinical preparation, including:

• evidence of an approved mentor/sponsor relationship,
• a clear dissertation or equivalent research training project,
• and an environment that can sustain the trainee’s planned scientific and clinical training trajectory.

The fellowship is intended for individual training in the U.S.. The funding structure is not a simple single stipend line item. NIH states that budget components include stipend, tuition and fees, and institutional allowance. It also clarifies that separate indirect costs (F&A) are not charged; administrative support is included in the institutional allowance model used in NRSA fellowships.

What remains critical is that exact stipend levels and tuition/institutional allowance figures are not fixed inside the NOFO text itself in the same way as call-specific budget ceilings. They are published annually and linked through NIH policy pages and NRSA program materials. If you need precise dollar numbers before submitting your budget, use:

• the official NIH NRSA program pages,
• current NIH policy notices linked from the NOFO,
• and the current application software forms used in ASSIST.

This matters because writing a realistic budget narrative and timeline requires current institutional allowance rates and expected support levels, especially for a long-cycle application (up to multi-year training).

Why this is relevant for 2026/2027

For teams looking at opportunities in the 2026 and 2027 windows, this PA is useful for two reasons:

1. It remains active through recurring standard due dates instead of closing after one date. The NOFO shows a running application calendar with multiple quarterly cycles, including August, December, and April cycles for 2026 and 2027.
2. The field is clear about who this is not for: schools with active NIH-funded institutional dual-degree programs and applications that propose to independently lead clinical trials. That clear scope makes triage easier for institutions that previously lose time submitting the wrong parent pathway.

As of the date used for this page metadata, the opportunity has open cycles in 2026 and 2027 and was still carrying recurring application schedule entries. Because NIH can adjust cycles and participating IC details through Notices of Special Interest and related instructions, applicants should treat each cycle as requiring a fresh institutional check.

Exact eligibility gates you must pass

Below are the concrete eligibility facts that determine whether your candidate profile can move forward.

Applicant organizations

The NOFO requires the sponsoring organization to be an eligible organization type in the usual NIH sense (universities, nonprofits, certain for-profits, eligible federal entities). The key exclusion is structural: the opportunity is for institutions without NIH-funded institutional predoctoral dual-degree programs in the target domains (MSTP/DSTP or similar).

This is the most common confusion point. A strong program office has to verify whether the institution currently has an NIH-supported dual-degree program of the same nature at the time your application is submitted for review.

Candidate profile

The fellow must be in an MD/PhD style dual-degree path or another recognized dual-doctoral combination (for example DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD, PharmD/PhD). The NOFO defines this carefully in two key ways:

• you should be enrolled in a formal dual-degree program,
• and you should have a defined dissertation research project and mentor(s).

There is also a timeline expectation: most candidates are expected to apply within 48 months of dual-degree matriculation and no later than 24 months into dissertation research training. There are exceptions for non-standard dual-degree structures or approved leave situations, but those are reviewed case-by-case by program staff.

The application must show real integration between clinical and research training. NIH explicitly requires that a large share of support time be spent in full-time graduate research training, with room for integrated clinical exposure according to the program structure.

Citizenship and residency

By the time of award, the candidate must meet U.S. citizenship or lawful permanent resident criteria as described in the NOFO. This is standard for this pathway, and institutions should validate legal documentation early.

Clinical trial restriction

This is explicit and strict: F30 applications under this parent announcement cannot propose candidate-led independent clinical trials. Clinical trial experience can be included if the applicant proposes to participate in a sponsor-led or co-sponsored trial.

Cost sharing

Cost sharing is not required. If your team has been told to pre-plan matching funds specifically for this mechanism, that requirement is not in this NOFO text, though institution-level obligations may exist in practice for other processes.

Application logistics and where teams fail most often

NIH opportunities with large applicant pools fail more on process than idea quality, especially with F and K mechanisms. PA-25-425 is no exception. The NOFO says all candidates should submit through NIH/Grants.gov systems with valid registrations. If those registrations are incomplete, even technically strong science can be delayed or rejected.

Required systems and sequencing

Use one of these:

• NIH ASSIST (preferred in many institutional workflows),
• institutional system-to-system route to Grants.gov and eRA Commons,
• or Grants.gov Workspace with eRA Commons tracking.

Before submission, your sponsoring organization must have complete registrations and valid institutional profile identifiers in place. NIH emphasizes that registration can take weeks. For teams in 2026/2027 cycles, the practical consequence is to complete systems setup before your target deadline.

Timing strategy for an August 2026 due date

The published cycle includes a due date of August 08, 2026 and other dates in 2026/2027. You should treat “due date” as a hard deadline and work backward from there:

• Now to 3 months before due date: finalize project, choose sponsor, gather biosketches and letters.
• Now to 2 months before: complete internal review, verify all registrations, and draft training plan.
• Now to 1 month before: test submission path end-to-end; this catches form or system issues.
• Last week: lock budget details and verify all sections with required NIH links, ethics statements, and references.

NIH explicitly notes candidates should apply early to allow submission corrections. That sentence should be treated as instruction, not suggestion.

What to submit as a coherent package

A PA-25-425 submission needs to make three things read as one coherent story:

• your scientific question,
• your mentored training path,
• and your long-term clinician-scientist trajectory.

NIH peer review is still criterion-driven, so your materials must map to each review stream:

• Candidate goals and potential,
• quality and feasibility of the research training plan,
• and mentoring and training environment strength.

The NOFO also includes additional review areas (human subjects, animals, biohazards, data sharing, resource sharing and eligibility checks). You do not need to over-claim; you need to show compliance and specificity.

Why this is a different decision process than standard project grants

Because this is an individual fellowship, reviewers evaluate candidate development as heavily as the project itself. In project-only R01 reviews, the project can carry much of the load. In F30 reviews, the candidate’s readiness, training need, and mentoring environment become equally central.

NIH describes review focus areas that should shape your application architecture:

• Candidate trajectory: evidence of strong preparation for independent research leadership.
• Research training plan: specific aims should include realistic milestones and clearly defined learning outcomes, not just publishable science.
• Mentoring and institutional fit: sponsor commitment and the training environment must convincingly support both research and clinical tracks.

A common misstep in this mechanism is writing only a project proposal and treating training as a checkbox section. The fellowship judges whether this is the right program for a career transition and skill development sequence.

Preparation playbook for a strong PA-25-425 application

1) Confirm institutional eligibility immediately

Check whether your institution currently has an NIH-funded predoctoral dual-degree program in the same category. If it does, this exact parent solicitation is not the right path. NIH’s current model includes a companion path for institutions that do have such programs.

2) Select a realistic project timeline

Fellows need a project aligned to dissertation timing, not a generic long-term science idea detached from real calendar constraints. Build your timeline around NIH’s expectation that support time can extend up to five years, with up to six years only in the dual-degree model.

3) Map training milestones explicitly

Reviewers are not only scoring your research hypothesis. They check whether your training milestones are appropriate and measurable:

• What skills do you gain in year one,
• what data generation or methods work is expected by year two,
• and how the proposed activities connect to clinical transition.

A strong mentor statement should describe how the sponsor will monitor and adapt this plan.

4) Build mentor and environment evidence into one narrative

The NOFO expects sponsor capability and institution quality as review evidence. Include

• access to necessary facilities,
• statistical or methodological support,
• and mentorship depth (not just one senior PI).

If a plan includes foreign research exposure, include strong justification with a clear scientific advantage argument; it is considered only when clearly warranted.

5) Pre-build submission compliance

Submit early and test your package against known constraints:

• all required registrations active,
• eRA Commons role permissions correct,
• sponsor and PI details aligned,
• RCR training plan included with at least eight contact hours,
• and human/animal sections completed for your project type.

6) Manage the NIH-specific details without over-optimistic claims

Do not overstate your clinical trial involvement. NIH under this PA allows participation in sponsor-led trials for training exposure, but not independent lead roles. If you misstate this, your application can be returned for correction or scored lower for scientific mismatch.

Common mistakes to avoid in 2026-2027 submissions

1. Submitting to the wrong parent announcement. This is the highest-frequency category error. Institutions with NIH-supported MSTP/DSTP-like programs must use the corresponding pathway.
2. Treating dual-degree timing loosely. If your stage and training milestones are too fuzzy, committees question feasibility and developmental fit.
3. Underbuilding mentorship evidence. A weak mentor section fails the environment criterion even with strong ideas.
4. Budgeting as if this were an R01. This mechanism uses fellowship components and NIH NRSA publication-policy-linked amounts, not an ad hoc discretionary pot.
5. Ignoring system readiness until submission week. Registrations and role setup are prerequisites; unresolved permissions create avoidable delays.
6. Weak RCR and compliance planning. The NOFO requires RCR coverage and review criteria include ethics, animal, and human-subject readiness when applicable.

Frequently asked questions

Is this opportunity open for 2027 only, or should I still apply now?

It is recurring, with multiple standard due dates across 2026 and 2027. The metadata here uses the 2026-08-08 cycle as an immediate anchor for planning, but you should monitor the official notice for the cycle closest to your readiness.

Can students in non-MD dual-degree programs apply?

Yes, where the dual-degree structure aligns with NIH’s accepted categories (for example DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD, PharmD/PhD). The NOFO focuses on combined dual-degree pathways and research project quality, not on medical degree branding alone.

Is the application renewable?

Fellowship awards are generally not renewable. In rare cases where further NRSA fellowship support is needed, NIH states rare renewals are not the default. Plan your timeline and milestones for full-cycle completion, not indefinite extension.

Can this support international travel or training abroad?

Foreign training is possible only with strong justification and scientific rationale. NIH’s review looks at whether the proposed international setting is demonstrably better than domestic alternatives.

Can non-academic entities apply as sponsoring orgs?

The NOFO supports several organization types, including eligible nonprofits and certain for-profit settings, but you must prove that the environment provides adequate facilities, mentorship, and training support.

How strict is the no-clinical-trial rule?

Strict for candidate-led independent trial leadership. Training participation in externally led trials is acceptable, but your proposal should not be framed as independent trial conduct.

Official links and monitoring points

Because this is a recurring NOFO, build your workflow around official NIH pages only:

• Official NOFO: https://grants.nih.gov/grants/guide/pa-files/PA-25-425.html
• NIH partnering and IC selection context: see the notice’s linked Participating Organizations section and Table of IC-Specific Information.
• How to apply guide: https://grants.nih.gov/grants/how-to-apply-application-guide (linked from the NOFO)
• eRA Commons: https://www.era.nih.gov/ (for tracking and access control context)
• Grants.gov: official submission channel for the workspace route

Bottom line

PA-25-425 is best thought of as a structured pathway, not a generic grant call. Its value is strongest for dual-degree trainees at institutions that do not already have NIH-funded MSTP/DSTP-style institutional support, especially when those trainees need a mechanism that explicitly funds research training and clinical integration together. In 2026 and 2027, it remains operational with recurring NIH cycles. The biggest advantage is access to the NRSA training ecosystem (stipend, tuition, and allowance components) if your profile and institutional context match exactly.

For a real submission decision, teams should confirm three things in this order: (1) organization-level program eligibility, (2) candidate-stage fit against the dual-degree and timeline constraints, and (3) full compliance readiness in ASSIST or Grants.gov/eRA workflows. If all three are solid, this opportunity is a strong match for candidate development and long-run clinician-scientist career preparation.